3D Antibody Characterization

Who are the top 4 Players in 3D Antibody Characterization?

Who are the top 4 Players in 3D Antibody Characterization? Therapeutic antibody engineering has been around for years. So what is keeping the number of therapeutic antibody treatments so relatively low when compared to small molecules and other types of therapeutics? Antibodies, and their therapeutic derivatives such as antibody-drug conjugates (ADCs), are complex, multi-faceted molecules that often require immense amounts …

Enabling Cell Therapy: Case Study on Scaling-Up Allogeneic Stem Cell Manufacturing From Multi-Tray Stacks To the Xpansion® MultiplateBioreactor

Sarah Snykers and Dr. Jose Castillo, Pall Life Sciences joined us at the 9th Annual World Stem Cells & Regenerative Medicine Congress to discuss ‘Enabling Cell Therapy: Case Study on Scaling-Up Allogeneic Stem Cell Manufacturing From Multi-Tray Stacks To the Xpansion® MultiplateBioreactor.’ Download this presentation now to find out: Promethera® Biosciences • Who we are? • Our process & product …

Identifying unique manufacturing challenges of Auto vs Allo cell based therapies

Dr Stephen Ward, Chief Operating Officer, Cell Therapy Catapult joined us at the 9th Annual World Stem Cells & Regenerative Medicine Congress to present on ‘Identifying unique manufacturing challenges of Auto vs Allo cell based therapies.’ Download this presentation now to find out: UK Regenerative Medicine Context Common Auto and Allo Challenges and Technical Solutions Common aims of Payers Manufacturing …

high potency API, HPAPI

Speakers discuss the high potency API industry ahead of HPAPI World Congress

Ahead of this November’s High Potency Active Pharmaceutical Ingredients (HPAPI) World Congress, next week in Geneva, we asked the industry-leading speaker faculty to reflect over the last 12 months and forecast what they thought the biggest opportunity will be for the sector moving forward. This winter, industry professionals from over a dozen international countries will be converging in the French-speaking …

Implementing an Enterprise Wide LMS

Some time back, not too long ago, the North American headquarters of a global Pharmaceutical company acquired several business units, and in an effort to standardize roles and consolidate training and qualifications, company leaders were seeking a single Learning Management System (LMS) to unify its eight operating companies and 7,000 employees. Leading the LMS evaluation were members of the Information …

BioPharma Mexico is where experts like SP Scientific meet to network, learn from each other, and discuss the latest developments in biopharma.

SP Scientific Shares Expertise on Controlled Nucleation in Freeze Drying

Mark Shon is Vice President of Technology Development for SP Scientific. His career includes over 20 years managing businesses that primarily develop and manufacture equipment for Life Sciences research, development and production. We were glad to have Mark join us for last year’s BioPharma Mexico. During the second day of the event, he gave a presentation on controlled nucleation in …

Numab, sponsors of the European Antibody Congress 2014

Guest Post: Numab – It is now possible to equip any bi- or multispecific antibody format with drug-like properties

Download Numab’s Guide to plug and play multispecific formats. Unsatisfactory CMC properties remain to be the major obstacle in the development of multispecific antibody therapeutics. In most cases it is the poor stability and the weak affinity of the Fv domains that lead to low production yields, aggregate formation and insufficient potency. Numab has mastered these problems with its technology that …

HPAPI Safety

What is the key to safe highly potent active pharmaceutical ingredient (HPAPI) manufacturing?

Innovating highly potent active pharmaceutical ingredient (HPAPI) production philosophies can ensure safety for those involved in their manufacturing, but what are the best pathways to innovate whilst reducing risks?   The fast growing HPAPI sector fosters huge potential, and with an annual growth rate exceeding double figures, it has become something of a ‘promised land’ to many CMOs. The market …

BioPharma México es donde vienen expertos cómo Birmex para network, aprender del otro, y discutir los desarrollos más recientes de la industria.

Birmex Discute el Mercado de Vacunas en México

Samuel Ponce de León es el director general de Laboratorios Biológicos y Reactivos de México (BIRMEX). Estudió medicina en la Universidad Nacional Autónoma de México (UNAM) con especialidad en medicina interna y enfermedades infecciosas en el Instituto Nacional de Nutrición. Realizó los estudios de maestría en epidemiología hospitalaria en la universidad de Virginia, Charlotresville en Estados Unidos. De 1991 a …

Increase in Continuous Processing and Single-Use in Future Biomanufacture Forecast in New Review

A review by Institute for Separation and Process Technology has predicted an increase in the use of single use technologies and continuous processing within the manufacture of biologics in the future. Researchers Jochen Strube, Reinhard Ditz and Petra Gronemeyer, predict that demands for high quality biologics will continue to increase in the coming decades. Decreasing production and imminent patent expirations of ‘blockbuster’ drugs coupled with a …